Recombinant Human PHLDA2 (C-6His)

Description

EnkiLife provides the Recombinant Human PHLDA2 (C-6His) protein,aslo know as Pleckstrin Homology-Like Domain Family A Member 2,Beckwith-Wiedemann Syndrome Chromosomal Region 1 Candidate Gene C Protein,Imprinted in Placenta and Liver Protein,Tumor-Suppressing STF cDNA 3 Protein,Tumor-Suppressing Subchromosomal Transferable Fragment Candidate Gene 3 Protein,p17-Beckwith-Wiedemann Region 1 C,p17-BWR1C,PHLDA2,BWR1C,HLDA2,IPL,TSSC3, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Pleckstrin Homology-Like Domain Family A Member 2 is produced by our E.coli expression system and the target gene encoding Met1-Pro152 is expressed with a 6His tag at the C-terminus.Accession:Q53GA4. Expression Host:E.coli.Species:Human.Predicted Molecular Mass:18.1 KDa. Background:Pleckstrin Homology-Like Domain Family A Member 2 (PHLDA2) is a peripheral membrane protein that belongs to the PHLDA2 family. PHLDA2 is expressed in the placenta and adult prostate gland. In the placenta, it is present in all cells of the villous cytotrophoblast. PHLDA2 plays a role in regulating placenta growth. PHLDA2 may act via its PH domain that competes with other PH domain-containing proteins, thereby preventing their binding to membrane lipids.